Registered Zambia · ZAMRA

Cobactan 2.5%

Cefquinome (as Cefquinome sulphate) 2.5 %

331/702V Suspension for Injection 2.5 %

What it does

Cefquinome is an antibiotic used to treat bacterial infections in animals.

Commonly used for: bacterial infections, respiratory infections, skin infections

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
331/702V
Registration date
2025-03-23
Expiry date
2030-03-22
Status
Registered/Compliant
Active ingredient
Cefquinome (as Cefquinome sulphate) 2.5 %
Strength
2.5 %
Pack size
-
Therapeutic class
-
Manufacturer / MAH
Intervet Productions
Country of origin
Italy
Manufacturer location
Via Nettunense, km 20.300, 04011 Aprilia LT, Italy

Source: Zambia Medicines Regulatory Authority · fetched 2026-03-12 00:06:28 · updated 2026-09-24 03:38:50

Disclaimer: This information is sourced from Zambia Medicines Regulatory Authority (Zambia). Always consult a qualified healthcare professional before using any medication.

About this medicine

Cefquinome is an antibiotic used to treat bacterial infections in animals.

What it treats

  • bacterial infections
  • respiratory infections
  • skin infections

How it works

Cefquinome kills bacteria by stopping them from forming their protective cell walls.

Who it's for

Cefquinome is used mainly in veterinary medicine for treating infections in livestock and pets.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: cefquinome

BNF-referenced

Cefquinome is a fourth-generation cephalosporin antibiotic that is primarily used in veterinary medicine. It possesses a broad spectrum of activity against both Gram-positive and Gram-negative bacteria. Cefquinome is particularly effective against certain strains of E. coli and Staphylococcus spp. Its use is limited to veterinary applications, and it is not approved for human use.

Indications

  • Bacterial infections in veterinary medicine
  • Treatment of respiratory tract infections
  • Treatment of skin and soft tissue infections
  • Treatment of urinary tract infections

Dosage

Children: Paediatric dosing should be guided by the BNF for Children. It is essential to refer to the specific dosing guidelines for children based on age, weight, and condition being treated.

Adults: The dosage for adults should be determined based on the specific condition being treated and the guidelines provided in the BNF. Consult the BNF for appropriate dosing recommendations.

Mechanism of action

Cefquinome works by inhibiting bacterial cell wall synthesis. It binds to penicillin-binding proteins (PBPs), which are essential for the cross-linking of peptidoglycan layers in bacterial cell walls. This leads to the disruption of cell wall integrity and ultimately results in bacterial lysis and death.

Pharmacodynamics

The pharmacodynamics of cefquinome involve its bactericidal activity, which is primarily time-dependent. The drug exhibits a prolonged post-antibiotic effect against certain bacteria, meaning it continues to inhibit bacterial growth even after serum levels have dropped below the MIC (minimum inhibitory concentration). Cefquinome is effective against a range of bacteria, including those that are resistant to other antibiotics.

Pharmacokinetics

Cefquinome is administered parenterally, with good bioavailability observed following intramuscular injection. It is widely distributed throughout the body, achieving therapeutic levels in various tissues. The drug is metabolized in the liver and is excreted primarily in the urine. The elimination half-life is approximately 1 to 2 hours, necessitating multiple doses for sustained therapeutic effect.

Pregnancy

Cefquinome should be used in pregnancy only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

Cefquinome is excreted in breast milk. Caution should be exercised when administering to nursing mothers.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

  • {'formulation': 'Cefquinome injection', 'strength': '100 mg/ml'}

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Molecular reference: cefquinome

PubChem CID 5464355

Molecular formula: C23H24N6O5S2

Source: PubChem (NCBI) · pathways from PathBank, Reactome, WikiPathways & PharmGKB.